Jumengda entered the big health industry in 2016, mainly engaged in plant-based probiotic solid beverages, and will add other gut health-related products in the future; protecting the gut health of 1.4 billion Chinese people has become Jumengda's mission. In 2017, it joined hands with T-Yan+ to participate in the World Health Industry Conference and Chinese Health Culture Expo, and was honored as a key recommended unit and an outstanding exhibitor, and its brand also won the honor of being among the Top 100 Outstanding Brands in the Health and Wellness Economy; in 2018, it underwent a strategic upgrade and owned its own brand "Yudingkang"; in 2019, Yudingkang's new products were officially launched; in order to upgrade its products and better serve customers, Jumengda jointly established a special R&D team with Gaofuji, reached a strategic cooperation with Switzerland, and established the Swiss Asian Gut Health Research Center. Jumengda also became a strategic cooperative member unit in Israel, possessing resources of a strain library with more than 1,500 strains, more than 20 patented collections, and more than 30 safety verifications. Its Yudingkang brand is one of the very few plant-based probiotics nationwide, and has successively won 3 first prizes for scientific and technological progress, 7 national and provincial-level achievement appraisals, and more than 110 proprietary intellectual property rights; in August 2019, the capital of Jumengda in the big health industry landed, with 310 channels developed, an internal valuation of RMB 200 million, releasing 10%, and successfully completing Series A financing. At the press conference, a Shanghai capital institution made a strategic investment in Jumengda; in 2020, Jumengda was invited to participate in the 2020 Chongqing 6.18 E-commerce Festival "Fall in Love with Chongqing · Enjoy Life in the Cloud" million-influencer sales promotion, becoming one of two among 100 companies invited to attend; in 2020, Jumengda and the Wenchuan Earthquake Disaster Area Reconstruction Fund established a special fund for food safety and health; in the same year, Jumengda's offline channels were upgraded across the board, with offline channels reaching 405, and its online platform underwent a strategic upgrade. The Jumengda Gut Health Comprehensive Service Platform went online. Jumengda's internal valuation was RMB 500 million, releasing 10%, and completing Series B financing. At the meeting, Morgan Capital completed the strategic signing ceremony for investment in Jumengda.
The company has obtained a private fund Tier-1 license and a securities Tier-2 license. Platform advantages
1. The company operates independently in wealth management and is not a third-party wealth management outsourcing service company.
2. The company has multiple mature and continuously operating private fund products. The return rate has maintained long-term excess performance. All have existed for more than 1 year and can accurately trace past performance.
3. The company's compensation follows the commission standards of coastal cities such as Shanghai and Shenzhen, and is generally better than various third-party wealth management companies for outsourced business
The name of the fund company under the group company: Youke Capital, and the company's office address is Yubei Jiazhou.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows